GAIA

Hamburg, Germany Founded: 2001 • Age: 25 yrs
Cloud-based digital therapeutics platform is provided for clinics.

About GAIA

GAIA is a Healthcare company based in Hamburg (Germany) founded in 2001. Cloud-based digital therapeutics platform is provided for clinics. It operates on a HealthTech model. The company has 96 employees. Its website gaia-group.com draws about 11 thousand monthly visits. GAIA offers products and services including deprexis® and Other Digital Therapeutics. Its focus areas include Digital Health and Digital Therapeutics. Its legal entity is GAIA AG.

Company details

Evidence-based digital therapeutics are developed by GAIA to assist patients in restoring and maintaining mental and physical health. Solutions are focused on offering similar effect sizes, safety profiles, and convenience as pharmaceutical options. The company operates in the healthcare sector, targeting major markets with a multidisciplinary team of experts in clinical science, IT, regulatory affairs, and market access. Products like deprexis for depression treatment are extensively tested in randomized controlled trials to ensure clinical effectiveness.

  • Headquarters Hamburg, Germany
  • Employees 96
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website gaia-group.com/en
  • Social LinkedIn X
  • Legal Name Gaia Ag
Key Metrics
  • Latest Funding Round
    $513.15K (USD), Grant

    Jan 2016

  • Investors
  • Employee Count
    96

Products & Services of GAIA

GAIA offers a comprehensive portfolio of products and services, including deprexis® and Other Digital Therapeutics.

deprexis®
Digital Therapeutics

Online program for depression treatment is clinically proven.

Other Digital Therapeutics
Digital Therapeutics

Various digital solutions for health are being developed.

Funding Insights of GAIA

  • Total Rounds 1
  • Last Round Grant — $513,147
  • First Round $513,147

    (Jan 2016)

  • Investors Count 1

All 1 funding rounds of GAIA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2016$513,147Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in GAIA

GAIA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for GAIA

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of GAIA

2 dated milestones of GAIA across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded GAIA is founded.
  2. Funding First funding round of $513K.

Web traffic of GAIA

The website of GAIA (gaia-group.com) receives about 11.4K visits a month and ranks #2,310,245 among all websites worldwide, #3,160 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    11.4K

    ▲ 40.9% vs previous month

  • Unique visitors
    3.1K

    per month

  • Global rank
    #2,310,245

    among all websites

  • Category rank
    #3,160

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with GAIA. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
borderline-netzwerk-berlin.de
borderline-netzwerk-berlin.de
100%
#6,280,190–
enableme.de
69%
#342,038View details
gaiagroup.org
gaiagroup.org
33%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gaia

Premium access

Complete news archive for GAIA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GAIA

GAIA was founded in 2001 and raised its 1st funding round 15 years after it was founded.

GAIA is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

GAIA has 96 employees.

Evidence-based digital therapeutics are developed by GAIA to assist patients in restoring and maintaining mental and physical health. Solutions are focused on offering similar effect sizes, safety profiles, and convenience as pharmaceutical options. The company operates in the healthcare sector, targeting major markets with a multidisciplinary team of experts in clinical science, IT, regulatory affairs, and market access. Products like deprexis for depression treatment are extensively tested in randomized controlled trials to ensure clinical effectiveness.

GAIA offers deprexis® and Other Digital Therapeutics.

GAIA has 1 investor. Key investors include European Union.

GAIA operates through Gaia Ag.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available